戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 in the two diabetic groups (with and without alpha-lipoic acid).
2 s produced by the oxidative stress scavenger alpha-lipoic acid.
3 le vitamins biotin and pantothenic acid, and alpha-lipoic acid.
4 inistration, a high-fat diet with or without alpha-lipoic acid (1.65 g/kg) was given to the mice and
5 s (4-benzoic acid) porphyrin (10 mg/kg), and alpha-lipoic acid (100 mg/kg).
6 decreased by preincubation with NAC (1 h) or alpha-lipoic acid (24 h) but not vitamin E.
7 receiving diets supplemented with or without alpha-lipoic acid (400 mg/kg) for 11 months of diabetes.
8 this deficit is dose-dependently reversed by alpha-lipoic acid, a change associated with an improveme
9 ar weights, and molar-mass dispersities from alpha-lipoic acid, a commercially available and renewabl
10  culture medium with 100, 200, or 500 microM alpha-lipoic acid, a metabolic antioxidant, after inocul
11                                          (R)-alpha-Lipoic acid, a mitochondrial coenzyme, is a powerf
12 melatonin, a naturally occurring indole, and alpha-lipoic acid, a naturally occurring dithiol, were a
13                     To examine the effect of alpha-lipoic acid, a potent natural antioxidant, on athe
14                                              alpha-Lipoic acid, a thiol antioxidant, has been shown t
15  OxPhos deficit in cINs could be reversed by Alpha Lipoic Acid/Acetyl-L-Carnitine (ALA/ALC) but not b
16                                              alpha-Lipoic acid administration for the entire duration
17 fold and 70%, respectively, in diabetes, and alpha-lipoic acid administration inhibited these increas
18                                The effect of alpha-lipoic acid administration on retinal 8-hydroxy-2'
19                                              Alpha lipoic acid (ALA) and vitamin C (Vit-C) are very i
20                                              Alpha lipoic acid (ALA) is a nutraceutical and potent an
21     Treating A-T cells with the antioxidant, alpha lipoic acid (ALA), restored mitochondrial respirat
22            Male SD rats were pretreated with alpha-lipoic acid (ALA) and dihydrolipoic acid (DHLA) or
23  to synthesize a new UV active derivative of alpha-lipoic acid (ALA) by its esterification with 4-met
24 ts with a racemic mixture of the antioxidant alpha-lipoic acid (ALA) could improve glucose metabolism
25                                              alpha-lipoic acid (ALA) is a potent antioxidant that is
26 onditions at a much lower concentration than alpha-lipoic acid (ALA).
27 ination of mixed tocopherols (666 IU/d) plus alpha-lipoic acid (ALA; 600 mg/d) or matching placebos f
28                     A nutraceutical, namely, alpha-lipoic acid (alpha-LA), is known for its potent an
29 f several antioxidant agents (ascorbic acid, alpha-lipoic acid, alpha-tocopherol, Mn(III)-tetrakis(4-
30                                  Polymers of alpha-lipoic acid (alphaLA) have the potential to fulfil
31                                              alpha-Lipoic acid (alphaLA) is an attractive building bl
32  mitochondria, lipoic acid synthase produces alpha-lipoic acid, an antioxidant and an essential cofac
33 dduct formation in human liver microsomes by alpha-lipoic acid, an inhibitor of NADPH: p450 reductase
34 l function and arborization were reversed by alpha lipoic acid and acetyl-L-carnitine treatments, whi
35 entation with the mitochondrial antioxidants alpha-lipoic acid and coenzyme Q(10) also suppresses Bak
36 ut normalized by treatment with antioxidants alpha-lipoic acid and D-alpha-tocopherol and, surprising
37 d, metformin, the combination treatment of R-alpha-lipoic acid and metformin, and niacin.
38 l derivatives of potent antioxidant vitamin, alpha-lipoic acid, and related analogues were designed,
39                                              Alpha-lipoic acid appears to be effective as well.
40             Polylipoates (PLp), derived from alpha-lipoic acid, are promising polymers for developing
41  under aqueous miniemulsion conditions using alpha-lipoic acid as a cheap and scalable building block
42         Diabetic rats were treated with 0.5% alpha-lipoic acid as a diet supplement or with hydroxyet
43                  Treating diabetic rats with alpha-lipoic acid but not HES-DFO partially improved sci
44                                  Remarkably, alpha-lipoic acid completely prevented the increase in p
45  systemic treatment with either HC-030031 or alpha-lipoic acid could completely prevent hypersensitiv
46 aining vitamin C, vitamin E, zinc, selenium, alpha-lipoic-acid, cranberry extract, grapeseed extract,
47                    Treatment with 500 microM alpha-lipoic acid decreased by 50% both the number and s
48 tration of either insulin or the antioxidant alpha-lipoic acid decreased proteinuria and oxidative st
49            The presence of 100 or 200 microM alpha-lipoic acid did not influence rickettsial growth i
50                                        Since alpha-lipoic acid does not seem to exhibit direct antiri
51                                              Alpha-lipoic acid dose- and time-dependently prevented t
52                          Pretreatment with R-alpha-lipoic acid effectively protected ARPE-19 cells fr
53 n of the cell culture medium with 100 microM alpha-lipoic acid for 72 h after infection prevented the
54 -doped carbon dots (Tb@N-CDs), combined with alpha-lipoic acid-functionalized copper nanoclusters (LA
55                                              Alpha-lipoic acid had a biphasic effect: it dose-depende
56                                              Alpha-lipoic acid had no significant effect on either en
57              The metabolic thiol antioxidant alpha-lipoic acid has been suggested to be of therapeuti
58 nstrate that the long-term administration of alpha-lipoic acid has beneficial effects on the developm
59 supplements studied, N-acetyl-L-cysteine and alpha-lipoic acid hold the most promise.
60 rovide further evidence for the potential of alpha-lipoic acid in treatment of diseases related to ox
61    We report that the nutritional supplement alpha-lipoic acid inhibits cystine stone formation in th
62                                              Alpha-lipoic acid is a potent antioxidant that prevents
63             Our results suggest that dietary alpha-lipoic acid is a promising protective agent for re
64 r 0.2% (wt/vol) in drinking water], and/or R-alpha-lipoic acid (LA) [0.2% or 0.1% (wt/wt) in diet].
65 e shown previously that the dithiol compound alpha-lipoic acid (LA) exerts antiinflammatory effects b
66                                              alpha-Lipoic acid (LA) has been found to attenuate diabe
67                                              alpha-Lipoic acid (LA) has been shown to improve memory
68                                              alpha-Lipoic acid (LA) has recently emerged as an attrac
69                        In diabetic patients, alpha-lipoic acid (LA) improves skeletal muscle glucose
70 d with the antioxidants vitamin E (VE) and R-alpha-lipoic acid (LA) in streptozotocin-induced diabeti
71                                              alpha-Lipoic acid (LA) is a cofactor for mitochondrial a
72                                              alpha-lipoic acid (LA) is an essential cofactor for mito
73 hombencephalic neurons and co-treatment with alpha-lipoic acid (LA) or one of several other antioxida
74 ed that 2 mo of dietary supplementation with alpha-lipoic acid (LA) prevented early glomerular injury
75 ects of administration of the antioxidant DL-alpha-lipoic acid (LA) to streptozotocin-injected diabet
76  statistical and block copolymers containing alpha-lipoic acid (LA) using reversible addition-fragmen
77              We investigated the role of (R)-alpha-lipoic acid (LA) vs. glutathione and ascorbic acid
78 ate whether dietary supplementation with (R)-alpha-lipoic acid (LA) was effective at reducing oxidati
79 rter (hSMVT) has been suggested to transport alpha-lipoic acid (LA), a potent antioxidant and anti-in
80  on the "grafting-through" polymerization of alpha-lipoic acid (LA)-functionalized macromonomers.
81 or the mitochondrial antioxidant precursor R-alpha-lipoic acid (LA).
82 ranslocation, old rats were treated with (R)-alpha-lipoic acid (LA; 40 mg/kg i.p. up to 48 h), a disu
83 % (wt/vol) in the drinking water] and/or (R)-alpha-lipoic acid [LA, 0.5% (wt/wt) in the chow] improve
84 yielding 600 g of poly(n-butyl acrylate-stat-alpha-lipoic acid) latexes that degrade under reducing c
85 ants regulated Ang II receptors differently: alpha-Lipoic acid lowered Ang II binding after 24 h, and
86 e retina is impaired and may be corrected by alpha-lipoic acid (LPA), a drug that inhibits vascular h
87 s for immediate testing in progressive MS: R-alpha-lipoic acid, metformin, the combination treatment
88 tioxidants ascorbate, ascorbate 2-phosphate, alpha-lipoic acid, N-acetyl-L-cysteine and glutathione i
89 iabetic rats, treatment with the antioxidant alpha-lipoic acid normalized the amount of leukostasis b
90 e of this study was to examine the effect of alpha-lipoic acid on retinal capillary cell apoptosis an
91 ls was not improved by treatment with either alpha-lipoic acid or HES-DFO.
92 acid, Trolox, Resveratrol, Alpha tocopherol, Alpha lipoic acid, Orotic acid, Ginsenoside RB1, and Xan
93  of drugs, choline (CHO), idebenone (IDB), R-alpha-lipoic acid plus acetyl-L-carnitine (LCLA), was fo
94               Application of the antioxidant alpha-lipoic acid potently prevents glucose-induced oxid
95                  Treating diabetic rats with alpha-lipoic acid prevented the diabetes-induced increas
96                                              Alpha-lipoic acid prevented the reduction in SCG creatin
97 supplementation of old animals with 0.5% (R)-alpha-lipoic acid prior to cell isolation almost complet
98 he antioxidants epigallocatechin gallate and alpha-lipoic acid reduces polyglutamine aggregation.
99 % or greater responder rate, flunarizine and alpha-lipoic acid (risk ratio [RR], 8.73; 95% CI, 2.44-3
100 ncubation with the AMPK activators AICAR and alpha-lipoic acid substantially prevented all of those c
101 nd their nondiabetic apoE(-/-) controls with alpha-lipoic acid supplement than in those without it.
102                                              Alpha-lipoic acid supplementation had no effect on gluco
103                                              alpha-Lipoic acid supplementation represents an achievab
104                  Conversely, the antioxidant alpha-lipoic acid, that protected against the loss of gl
105                                 Lipoic acid (alpha lipoic acid, thioctic acid) is a popular over-the-
106                       Simple formulations of alpha-lipoic acid (up to 10 mol %), n-butyl acrylate, a
107 treatment regardless of the concentration of alpha-lipoic acid used.
108        Duration of diabetes was 1 month, and alpha-lipoic acid was administered intraperitoneally 5 t
109                  These protective effects of alpha-lipoic acid were accompanied by a reduction of pla
110  of acrolein and the protective effects of R-alpha-lipoic acid were examined with a variety of previo
111      Dihydrolipoic acid (the reduced form of alpha-lipoic acid), which contains free sulfhydryl group
112  receptor binding in cell membranes, whereas alpha-lipoic acid, which does not contain free sulfhydry
113                              Substitution of alpha-lipoic acid with ethyl lipoate further improves th

 
Page Top